🇺🇸 FDA
Patent

US 7919579

Imaging and therapeutic targeting of prostate and bladder tissues

granted A61KA61K47/645A61K51/088

Quick answer

US patent 7919579 (Imaging and therapeutic targeting of prostate and bladder tissues) held by The Board of Regents of the University of Texas System expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K47/645, A61K51/088, A61P, A61P35/00